New Leaf Venture Partners’s Tectonic Therapeutic TECX Stock Holding History

New Leaf Venture Partners’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,296	Closed	-$316K	–	15
2023 Q1	$316K	Hold	26,296	–	–	0.26%	15
2022 Q4	$225K	Hold	26,296	–	–	0.16%	16
2022 Q3	$203K	Hold	26,296	–	–	0.12%	17
2022 Q2	$290K	Hold	26,296	–	–	0.19%	20
2022 Q1	$417K	Hold	26,296	–	–	0.21%	20
2021 Q4	$1.22M	Hold	26,296	–	–	0.44%	18
2021 Q3	$1.76M	Hold	26,296	–	–	0.51%	19
2021 Q2	$2.81M	Hold	26,296	–	–	0.72%	14
2021 Q1	$4M	Hold	26,296	–	–	0.93%	12
2020 Q4	$4.4M	Hold	26,296	–	–	1.02%	12
2020 Q3	$4.11M	Hold	26,296	–	–	1.66%	9
2020 Q2	$5.51M	Hold	26,296	–	–	1.58%	9
2020 Q1	$4.91M	Hold	26,296	–	–	1.47%	9
2019 Q4	$6.35M	Hold	26,296	–	–	1.38%	10
2019 Q3	$4.46M	Buy	26,296 +8,333	+46%	+$1.89M	1.35%	11
2019 Q2	$3.5M	Hold	17,963	–	–	0.94%	15
2019 Q1	$4.75M	Hold	17,963	–	–	1.3%	13
2018 Q4	$3.59M	Buy	17,963 +3,600	+25%	+$1.1M	0.99%	14
2018 Q3	$8.94M	Buy	14,363 +1,863	+15%	+$826K	1.63%	11
2018 Q2	$4.28M	Buy	+12,500	New	+$4.51M	1.03%	11

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New Leaf Venture Partners's TECX Position: Q2 2023 in Review

New Leaf Venture Partners sold out of Tectonic Therapeutic (TECX) in Q2 2023, closing a stake of 26,296 shares — an estimated $316K sold.

New Leaf Venture Partners first reported a position in TECX in Q2 2018 and held it in 20 quarters. The position peaked at $8.94M in Q3 2018. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2023.

New Leaf Venture Partners reported no remaining Tectonic Therapeutic position as of Q2 2023 after selling out during the quarter.
New Leaf Venture Partners sold 26,296 Tectonic Therapeutic shares in Q2 2023, an estimated $316K.
New Leaf Venture Partners first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 20 quarters.
New Leaf Venture Partners's Tectonic Therapeutic position peaked at $8.94M in Q3 2018.
40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2023.

Based on New Leaf Venture Partners's 13F filing for Q2 2023, filed 10 Aug 2023.